Wednesday, March 18, 2026 2:55:40 PM
Two different topics below...
1.) A recurring theme with CBD is that it enhances the efficacy of a variety of other medicines without enhancing the negative side effects...here is a new paper on CBD+Probiotics that again shows "synergy"...
"Synergistic Neuroimmune Modulation by Cannabidiol and Probiotics for Therapeutic Advancement in CNS Disorders: A Systematic Review":
10 March 2026
https://www.benthamdirect.com/content/journals/cnsnddt/10.2174/0118715273411035251111055748
2.) Full spectrum cannabis oil outperforms placebo in Dogs with Arthritis...
"Randomized and Blind Evaluation of the Efficacy of a Full-Spectrum Oral Cannabis sativa Oil Extract, Standardized Based on CBD-A, CBD and THC-A, THC in Canines with Chronic Osteoarthritis":
12 March 2026
https://www.mdpi.com/2076-2615/16/6/900
1.) A recurring theme with CBD is that it enhances the efficacy of a variety of other medicines without enhancing the negative side effects...here is a new paper on CBD+Probiotics that again shows "synergy"...
"Synergistic Neuroimmune Modulation by Cannabidiol and Probiotics for Therapeutic Advancement in CNS Disorders: A Systematic Review":
10 March 2026
The observed benefits of CBD and probiotics suggest a synergistic mechanism through gut-brain axis modulation, addressing both neurological and immunological pathways.
https://www.benthamdirect.com/content/journals/cnsnddt/10.2174/0118715273411035251111055748
2.) Full spectrum cannabis oil outperforms placebo in Dogs with Arthritis...
"Randomized and Blind Evaluation of the Efficacy of a Full-Spectrum Oral Cannabis sativa Oil Extract, Standardized Based on CBD-A, CBD and THC-A, THC in Canines with Chronic Osteoarthritis":
12 March 2026
Results showed an important reduction in CBPI scores in the Cannabis group, compared to the Placebo group, and a slight increase in the Control group. Additionally, more than 50% of dogs in the Cannabis group improved one stage on the COAST scale, with no changes in the other groups, with no adverse effects observed.
https://www.mdpi.com/2076-2615/16/6/900
Recent CWBHF News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/13/2026 11:08:56 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/13/2026 11:07:49 AM
- Charlotte's Web First Quarter 2026 Financial Results • Newsfile • 05/13/2026 11:07:00 AM
- OTC Markets Group Welcomes Charlotte's Web Holdings Inc. to OTCQX • GlobeNewswire Inc. • 04/30/2026 11:00:00 AM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/16/2026 07:03:53 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/16/2026 07:03:14 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/16/2026 07:02:48 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 04/14/2026 04:30:15 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 04/06/2026 09:07:26 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/03/2026 06:32:55 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/03/2026 06:31:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/03/2026 06:29:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2026 11:18:49 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/01/2026 09:30:13 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/01/2026 09:29:45 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/31/2026 11:08:26 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/31/2026 11:07:30 AM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 03/31/2026 11:07:11 AM
- Charlotte's Web Reports 2025 Fourth Quarter and Full Year Financial Results • PR Newswire (US) • 03/31/2026 11:07:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/31/2026 10:46:21 AM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 03/31/2026 10:45:01 AM
- Charlotte's Web Announces Transaction with BAT: Debenture Conversion and US$10M Equity Investment to Strengthen Balance Sheet • PR Newswire (US) • 03/31/2026 02:59:00 AM
- Charlotte's Web 2025 Fourth Quarter and Year-End Earnings Call and Webcast Notice • PR Newswire (US) • 03/24/2026 01:15:00 PM
- Charlotte's Web Welcomes New CMS Guidance, Advancing Access to Eligible Full‑Spectrum Hemp Products • PR Newswire (US) • 03/21/2026 01:53:00 AM
